Skip to content

Artiva Biotherapeutics (ARTV) IPO deck

Artiva is an immunotherapy company with the ability to produce off-the-shelf, allogeneic NK cell therapies at a massive scale.

This post is for subscribers only

Subscribe

Already have an account? Sign In

Latest